3 completed, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 3, Terminated 1 |
Follow Impetigo: new trials by email Literature Review of Impetigo trials Research Report on Impetigo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Azithromycin - Ivermectin Mass Drug Administration for Skin Disease Ivermectin, Azithromycin, Permethrin - Scabies, Yaws | Phase 4 | Completed | London School of Hygiene and Tropical Medicine | 1291 | 2016-07-01 | 2019-09-17 |
| Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection Retapamulin (Altabax) - Impetigo, Folliculitis | Phase 4 | Completed | The University of Texas Health Science Center, Houston | 38 | 2010-04-01 | 2016-02-17 |
| Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. Retapamulin Ointment, 1% - Skin Infections, Bacterial | Phase 4 | Completed | GlaxoSmithKline | 60 | 2007-09-01 | 2016-12-28 |
| Fucidin® Cream in the Treatment of Impetigo Fucidin® cream - Impetigo | Phase 4 | Terminated | LEO Pharma | 58 | 2004-05-01 | 2025-03-06 |
Infections (2) · Cellulitis (1) · Dermatitis, Atopic (1) · Eczema (1) · Folliculitis (1) · Scabies (1) · Skin Abnormalities (1) · Skin Diseases (1) · Sudden Infant Death (1) · Yaws (1)
Bacterial Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Positive Bacterial Infections (4) · Skin Diseases, Bacterial (4) · Skin Diseases, Infectious (4) · Skin and Connective Tissue Diseases (4) · Staphylococcal Infections (4) · Staphylococcal Skin Infections (4) · Streptococcal Infections (4) · Skin Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Infections (2) · Congenital Abnormalities (1) · Connective Tissue Diseases (1) · Death (1)
Azithromycin (1) · Ivermectin (1) · Permethrin (1) · retapamulin (1)
GlaxoSmithKline (1) · LEO Pharma (1) · London School of Hygiene and Tropical Medicine (1) · The University of Texas Health Science Center, Houston (1)
United States (2) · Argentina (1) · Chile (1) · Costa Rica (1) · Germany (1) · Mexico (1) · Netherlands (1) · Norway (1) · Solomon Islands (1) · South Africa (1) · Sweden (1) · Taiwan (1)
Adelaide A Hebert, M.D. (1) · Michael Marks (1)